ER(+)/HER2(+) and ER-/HER2(+) breast cancers might have different intracranial recurrence patterns after brain-directed radiation for brain metastases

Altundag Kadri

首页> 外文期刊>Breast cancer research and treatment. >ER(+)/HER2(+) and ER-/HER2(+) breast cancers might have different intracranial recurrence patterns after brain-directed radiation for brain metastases

【24h】

ER(+)/HER2(+) and ER-/HER2(+) breast cancers might have different intracranial recurrence patterns after brain-directed radiation for brain metastases

机译：ER（+）/ HER2（+）和ER-/ HER2（+）乳腺癌可能在脑导向辐射后具有不同的颅内复发模式，用于脑转移

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Breast cancer research and treatment.》 |2019年第1期|共1页
作者
Altundag Kadri;
展开▼
作者单位

MKA Breast Canc Clin TR-06800 Ankara Turkey;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. ER(+)/HER2(+) and ER-/HER2(+) breast cancers might have different intracranial recurrence patterns after brain-directed radiation for brain metastases [J] . Altundag Kadri Breast cancer research and treatment. . 2019,第1期

机译：ER（+）/ HER2（+）和ER-/ HER2（+）乳腺癌可能在脑导向辐射后具有不同的颅内复发模式，用于脑转移
2. ER+/HER2(+) Breast Cancer Has Different Metastatic Patterns and Better Survival Than ER-/HER2(+) Breast Cancer [J] . Arciero Cletus A., Guo Yi, Jiang Renjian, Clinical breast cancer . 2019,第4期

机译：ER + / HER2（+）乳腺癌具有不同的转移模式和比ER-/ HER2（+）乳腺癌更好的存活
3. Patterns of protein expression and signaling assessed by reverse phase protein array (RPPA) in estrogen-receptor negative (ER-), HER2-amplified breast cancer (BC) that was primary-refractory to preoperative (preop) HER2-directed therapy [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：通过反相蛋白阵列（RPPA）在雌激素受体阴性（ER-），HER2-扩增的乳腺癌（BC）中评估的蛋白质表达和信号传导，其是术前（PREOP）HER2-定向治疗的主要难治
4. Peptide-based immuno-MRM-MS quantification of ER and HER2 in breast cancer cell lines, fresh frozen tissues, and FFPE tissues [C] . Regine M. Schoenherr, Jeffrey R. Whiteaker, Richard G. Ivey, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

机译：基于肽的免疫-MRM-MS定量ER和HER2在乳腺癌细胞系，新鲜冷冻组织和FFPE组织中
5. HER2Delta16: a tumor-specific oncogene that drives tumorigenesis and trastuzumab resistance in HER2+ breast cancer. [D] . Huynh, Felicia C. 2015

机译：HER2Delta16：一种肿瘤特异性癌基因，可驱动HER2 +乳腺癌的肿瘤发生和曲妥珠单抗。
6. Is Expression or Activation of Src Kinase Associated with Cancer-Specific Survival in ER- PR- and HER2-Negative Breast Cancer Patients? [O] . Beatrix Elsberger, Bingchao A. Tan, Thomas J. Mitchell, 2009

机译：Src激酶的表达或激活与ERPR和HER2阴性乳腺癌患者的癌症特异性存活率相关吗？
7. ER+/HER2+ Breast Cancer Has Different Metastatic Patterns and Better Survival Than ER−/HER2+ Breast Cancer [O] . Cletus A. Arciero, Yi Guo, Renjian Jiang, 2019

机译：ER + / HER2 +乳腺癌具有不同的转移模式和比ER-/ HER2 +乳腺癌更好的存活
8. CSrc and Her2 Signaling Pathways Cooperate with Estrogen to Promote ER Phosphorylation, Ubiquitination and Proteolysis in ER Negative Breast Cancers [R] . Chu, I. 2007

机译：Csrc和Her2信号通路与雌激素合作促进ER阴性乳腺癌的ER磷酸化，泛素化和蛋白水解

ER(+)/HER2(+) and ER-/HER2(+) breast cancers might have different intracranial recurrence patterns after brain-directed radiation for brain metastases

著录项

相似文献

相关主题

期刊订阅